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A B S T R A C T
Melanopsin retinal ganglion cells (mRGCs) are intrinsically photosensitive RGCs deputed to non-image forming
functions of the eye such as synchronization of circadian rhythms to light-dark cycle. These cells are character-
ized by unique electrophysiological, anatomical and biochemical properties and are usually more resistant than
conventional retinal ganglion cells to different insults, such as axotomy and different paradigms of stress. We
also demonstrated that these cells are relatively spared compared to conventional RGCs in mitochondrial optic
neuropathies, i.e. Leber's hereditary optic neuropathy and Dominant Optic Atrophy. However, these cells are
affected in other neurodegenerative conditions, such as glaucoma and Alzheimer's disease. We here review the
current evidences that may underlie this dichotomy. We also present our unpublished data on cell experiments
demonstrating that melanopsin itself does not explain the robustness of these cells and some preliminary data on
immunohistochemical assessment of mitochondria in mRGCs.
1. Introduction
Melanopsin-expressing retinal ganglion cells (mRGCs) represent the
third class of photoreceptors in the retina, the two other being rods and
cones. The mRGCs are mainly involved in the non-image forming func-
tions of the eye, with a crucial role in photoentrainment of circadian
rhythms (Hannibal et al., 2002; Hannibal, 2002; Berson et al., 2002;
Hattar et al., 2002; Do and Yau, 2010). The discovery of the non-im-
age forming system was prompted by the observation that in mice mod-
els of retinal degeneration, light was still able to photoentrain circadian
rhythms (Foster et al., 1991; Freedman et al., 1999; Lucas et al., 1999),
thus the existence of a novel photoreceptor was postulated. In 2002, af-
ter identification of the melanopsin photopigment, a G-protein coupled
receptor with structural similarities to the opsin family of photorecep-
tors (Provencio et al., 1998, 2000), converging evidences showed that
a small subset of RGCs express melanopsin in their membrane allow-
ing the cells to be intrinsically photosensitive. The mRGCs project to the
hypothalamic suprachiasmatic nucleus (SCN) through the retino-hy-
pothalamic tract (RHT) (Gooley et al., 2001; Hannibal et al., 2002;
Hannibal, 2002; Hattar et al., 2002; Berson et al., 2002). The RHT,
a monosynaptic anatomical pathway connecting the eye to the SCN
(Moore and Lenn, 1972; Sadun et al., 1984; Moore et al., 1995) is now
established to originate from mRGCs (Hannibal et al., 2002; Hannibal,
2002; 2004; 2014; Hattar et al., 2002, 2006; Berson et al., 2002). Be-
sides photoentrainment of circadian rhythms, these cells play a role in
other non-image forming functions of the eye such as pupil light re-
sponse (PLR), regulation of melatonin synthesis, mood, sleep, cognition
and light-aversion (Legates et al., 2012). In addition, a possible role in
visual functions has been proposed (Estevez et al., 2012).
The mRGCs represent less than 1% of the RGCs in humans (Hannibal
et al., 2004, La Morgia et al., 2010, 2016; Liao et al., 2016; Dacey et
al., 2005). These cells are characterized by a large soma and in hu-
mans approximately equal proportions are located in the retinal gan-
glion cell and the inner nuclear layer (La Morgia et al., 2010). Stud-
ies primarily in mice, based on the level of melanopsin expression, den
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dritic field arborization, physiology and central projections, classified
the mRGCs into five subtypes (Baver et al., 2008; Ecker et al., 2010,
Schmidt et al., 2011a, 2011b). The best characterized are M1, strat-
ifying in the outermost sublamina of the inner plexiform layer (IPL),
the M2 stratifying in the innermost sublamina of the IPL and the bis-
tratifying M3 cells with dendrites in both inner and outer sublamina
(Schmidt et al., 2011a, 2011b). Melanopsin is expressed primarily in the
membrane of the soma and dendrites and even in the axons running
within the retinal nerve fiber layer, and the large and imbricated den-
dritic fields constitute a photoreceptive net in the retina (Provencio et
al., 2002; Hannibal et al., 2014, Liao et al., 2016; Hannibal et al., 2017;
Nasir-Ahmad et al., 2017).
The mRGCs are characterized by unique photoreceptive properties
resembling invertebrate photoreceptors e.g. by depolarization in re-
sponse to light stimuli and possibly displaying bi-or tristability i.e. not
being dependent on other cells for chromophore isomerization (Isoldi et
al., 2005; Do and Yau, 2010; Brown, 2016). Melanopsin is maximally
sensitive to short wavelength blue light (peak response at 480 nm), and
mRGCs present a sustained response to light, which can persist even af-
ter the light has been switched off (Do and Yau, 2010). Although mRGCs
are independently functioning photoreceptor cells, they receive inputs
from rods and cones through amacrine and bipolar cells (Viney et al.,
2007; Belenky et al., 2003), thus constituting an “irradiance-detector”
system in the eye (Viney et al., 2007; Jusuf et al., 2007; Do and Yau,
2010).
The phylogenic and ontogenic importance of this cellular system
is demonstrated by the fact that melanopsin has been discovered in
a number of vertebrate organisms, and that in rodents these cells re-
spond to light at post-natal day 0, long before the classic photorecep-
tors, i.e. rods and cones are functional (Hannibal and Fahrenkrug, 2004;
Sekaran et al., 2005; Tu et al., 2005; Koyanagi and Terakita, 2008;
Davies et al., 2010; González-Menéndez et al., 2010). The importance
of the melanopsin-based system is supported by the observation that in
the subterranean blind mole rat, the circadian photoentrainment per-
sists due to residual presence of mRGCs projecting to brain structures
deputed to control circadian rhythms (Cooper et al., 1993; Hannibal et
al., 2002; Esquiva et al., 2016). Moreover, there is consistent evidence
that mRGCs are more resistant to injury such as axotomy and survive
different paradigms of stress (Cui et al., 2015; Rovere et al., 2016) and
metabolic dysfunction such as in mitochondrial optic neuropathies (La
Morgia et al., 2011). However, in other pathological conditions such as
Alzheimer's disease and glaucoma, these cells are affected (La Morgia
et al., 2016; Drouyer et al., 2008; Pérez-Rico et al., 2010; Obara et al.,
2016; Valiente-Soriano et al., 2015). In this paper, we will review this
dichotomy, in addition to present unpublished data on the topic.
2. Models of stress and robustness of mRGCs
2.1. Optic nerve transection
Hollander and colleagues (Holländer et al., 1985) and von Bussman
and colleagues (von Bussmann et al., 1993) reported that a small sub-
set of RGCs survived optic nerve transection. In particular, von Bussman
and colleagues demonstrated that this subset (about 1%) of cells had
large bodies and were intensively stained with cytochrome c oxidase
(COX) (von Bussmann et al., 1993), which suggests that mRGCs are the
surviving cells; subsequent studies have indeed demonstrated increased
resistance of mRGCs to optic nerve transection in rodents (Robinson
and Madison, 2004; Li et al., 2008; Nadal-Nicolás et al., 2015; Pérez de
Sevilla Müller et al., 2014).
2.2. Mitochondrial optic neuropathies
In humans, it has been demonstrated that patients suffering blind-
ing disorders with either extensive damage of rods and cones, as seen in
outer retinopathies or certain optic neuropathies, maintained the mela-
tonin suppression response induced by light and the circadian entrain-
ment to the light/dark cycle (Zaidi et al., 2007; Czeisler et al., 1995;
Pérez-Rico et al., 2009).
Inherited optic neuropathies due to mitochondrial dysfunction such
as Leber's hereditary optic neuropathy (LHON) and dominant optic at-
rophy (DOA) are both characterized by selective loss of RGCs (Carelli et
al., 2004; Yu-Wai-Man et al., 2011). We have studied the mRGC system
in these optic neuropathies by evaluating the melatonin suppression re-
sponse to light in affected LHON and DOA patients. In addition, we have
immunohistochemically stained the mRGCs in postmortem retinal and
optic nerve specimens from LHON and DOA patients and controls. Both
LHON and DOA patients had a melatonin suppression response induced
by light comparable to controls, and the immunohistochemistry of reti-
nal and optic nerve specimens revealed that mRGCs were preferentially
spared compared to non-mRGCs (La Morgia et al., 2010). The obser-
vation that mRGCs are relatively spared in mitochondrial optic neu-
ropathies explains the maintenance of the pupillary light reflex (PLR), a
peculiar and previously unexplained clinical feature of LHON (Bremner
et al., 1999; La Morgia et al., 2010, 2011). Other studies have subse-
quently confirmed these findings by assessing the PLR (Kawasaki et al.,
2010; Moura et al., 2013; Nissen et al., 2015). Furthermore, a mouse
model with rotenone-induced optic neuropathy mimicking LHON was
also shown to maintain the PLR (Zhang et al., 2006).
Perganta and colleagues showed preservation of mRGCs in a mouse
model of DOA (B6; C3-Opa1⁠Q285STOP) (Perganta et al., 2013). Strik-
ingly, the mRGC preservation in another DOA mouse model
(B6;C3-Opa1⁠329-355del) persisted after breeding with melanopsin deficient
mice (OPN4 ⁠−/−) proving that mRGC resistance seems to be indepen-
dent from melanopsin expression (González-Menéndez et al., 2015).
Overall, these observations suggest that mRGCs may have specific
properties that make them more resistant to neurodegeneration in mito-
chondrial optic neuropathies.
2.3. Other injuries
Other evidences of mRGC robustness are provided by studies on
cell toxicity to monosodium glutamate (Chambille and Serviere, 1993;
Hannibal et al., 2001) and NMDA-induced excitoxicity (DeParis et al.,
2012). The robustness of mRGCs to other different stressful insults re-
mains, however, an open question, which needs specifically dedicated
studies.
3. Models of mRGC vulnerability and loss
3.1. Alzheimer's disease
Alzheimer's disease (AD) is a neurodegenerative disorder character-
ized by the occurrence of circadian and sleep dysfunction even in the
early stages (Mattis and Sehgal, 2016). The presence of neuronal loss
and AD pathology has been reported in the SCN of AD patients (Swaab
et al., 1985; Stopa et al., 1999; Harper et al., 2008). Moreover, a recent
longitudinal study demonstrated that sleep fragmentation is correlated
to neuronal loss in the SCN in AD patients (Lim et al., 2014).
Optic neuropathy has also been described in AD, as confirmed by
both histological and optical coherence tomography (OCT) studies
(Hinton et al., 1986, Coppola et al., 2015). We recently demonstrated
that mRGCs are lost and affected by amyloid AD pathology in post
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mortem retinas of AD patients, possibly contributing to the circadian
dysfunction observed in AD (La Morgia et al., 2016). Thus, in AD
mRGCs are vulnerable to amyloid pathology. Interestingly, the mRGC
loss in AD occurred even with a completely normal count of conven-
tional RGCs, pointing to a primary AD pathology selectively affecting
these cells (La Morgia et al., 2016).
3.2. Glaucoma
Glaucoma is a common ocular degenerative disease that affects pri-
marily the inner retina. Reports on mRGCs in glaucoma are contradic-
tory. An initial study pointed to mRGC resistance in an animal model
of glaucoma (Li et al., 2006), while another study reported that mRGC
are lost with disease progression, possibly in relation to increased in-
traocular pressure (IOP) in older animals (Zhang et al., 2013). However,
in other rodent models mRGCs are reported to be vulnerable to IOP
damage to the same extent as conventional RGCs (Drouyer et al., 2008;
de Zavalía et al., 2011) and recently, in experimental rat and mouse
glaucoma models, a 50% loss of mRGCs was described (Vidal-Sanz et
al., 2015). Similarly, human functional studies investigating PLR and
light-induced nocturnal melatonin suppression in glaucoma patients
have reported reduced responses in patients compared to controls sug-
gesting a vulnerability of mRGCs in glaucoma (Gracitelli et al., 2016,
2015, 2014; Kelbsch et al., 2016; Pérez-Rico et al., 2010; Nissen et al.,
2014; Rukmini et al., 2015). However, in a severely affected glaucoma
patient Zhou and colleagues showed persistence of the PLR implicating
the survival of mRGCs despite the severe optic neuropathy (Zhou et al.,
2014). We have recently shown, that mRGCs are reduced in severe glau-
coma compared to age-matched controls, but with a relative sparing of
displaced mRGCs (Obara et al., 2016).
Overall, the large majority of studies point to some vulnerability of
mRGCs to glaucomatous damage leading to the occurrence of circadian
rhythm dysfunction. Noticeably, a higher prevalence of glaucoma has
been reported in AD (Bayer et al., 2002) compared to controls, and the
pattern of optic nerve fiber loss in AD resembles that described in glau-
coma (La Morgia et al., 2016).
4. Hypothetical mechanisms of mRGC resistance in mitochondrial
optic neuropathies
The specific vulnerability of conventional RGCs in mitochondrial op-
tic neuropathies, leading to optic atrophy, is currently ascribed to the
long intraretinal unmyelinated axonal segment of the RGCs (Carelli et
al., 2004; Yu-Wai-Man et al., 2011; Sadun et al., 2013). In humans, this
unmyelinated axonal segment is needed for transparency of the retina
to light. It has been argued that a byproduct of this anatomical feature
is the exposure of RGCs to the damaging effect of light, in particular
to short wavelength blue light (Osborne et al., 2014). However, there is
more compelling evidence that non-myelinated membrane is metaboli-
cally expensive and the rate of RGC axonal degeneration can be math-
ematically modeled precisely taking these features into account (Pan et
al., 2012). Within the RGC population, the subset of mRGCs may bet-
ter cope with light due to the expression of melanopsin. Thus, a logi-
cal first hypothesis for mRGC resistance to mitochondrial dysfunction is
the natural protection provided by the melanopsin photopigment. How-
ever, a recent study by Gonzalez-Menendez and collaborators provided
evidence that mRGC resistance persists in an animal model of DOA
despite the lack of melanopsin expression (González-Menéndez et al.,
2015). We also tested the possible protective role of melanopsin using
an in-vitro human cell model and here report these previously unpub-
lished results. In addition, we evaluated the mitochondrial abundance
in mRGCs and conventional RGCs by immunohistochemistry on human
retinal sections.
4.1. Experiments with HEK-hMel cells
We hypothesized that expression of melanopsin, specific to mRGCs,
may be responsible for their metabolic robustness. To test if melanopsin
expression indeed influences cell viability in different stressful para-
digms, we used the human embryonic kidney cell line HEK-293 modi-
fied to stably express human melanopsin under the control of a tetra-
cycline-sensitive promoter (HEK-hMel) (Georg et al., 2014). The experi-
ment was performed with cells either in the presence or absence of 1 μg/
mL tetracycline that elicits maximal melanopsin expression. The cells
grown in absence of tetracycline and, thus, not expressing melanopsin
served as controls. The effect of pro-oxidant challenge with rotenone
or tert-butyl-hydroperoxide (TBH) on survival of the cells was evalu-
ated by the sulforhodamine B (SRB) absorbance, as previously described
(Porcelli et al., 2009). Rotenone is a respiratory complex I inhibitor,
which induces ROS production within mitochondria, thus simulating
the pathological condition determined by the LHON mtDNA mutations.
TBH induces a cytoplasmic increase of ROS, representing a different par-
adigm of ROS exposure. Fig. 1 shows results of experiments (n = 3)
performed during darkness. We applied increasing concentrations of
rotenone (0.5 μM; 2.5 μM; 5 μM) or TBH (50 μM; 200 μM) to the cells
either expressing or not melanopsin, and both in the presence or ab-
sence of the chromophore retinal (5 μM). Fig. 1 shows that increasing
concentration of both rotenone and TBH, as expected, affected cell sur-
vival negatively. However, expression of melanopsin did not influence
significantly cell survival nor did the presence of the chromophore reti-
nal.
To test whether exposure to light affected cell viability during oxida-
tive stress, we exposed the cells to either white or blue (480 nm) light
for 30 min during rotenone or TBH challenge. We obtained similar re-
sults irrespective of wavelength. Fig. 2 shows the results obtained by ex-
posing the cells to blue light. Fig. 2A shows the results obtained with
rotenone and 2B those with TBH.
4.2. Immunohistochemistry assessment of mitochondria in mRGCs
To assess the abundance of mitochondria in mRGCs and conven-
tional RGCs we performed immunohistochemical analysis on post-
mortem ocular specimens from a LHON (male, aged 52) and a control
(male, aged 59). Serial formalin-fixed paraffin-embedded retinal sec-
tions were stained either with antibodies against melanopsin (La Morgia
et al., 2010) or against a mitochondrial extract (UCS Diagnostic), the mi-
tochondrial respiratory chain enzyme subunits ND6 (Mitosciences) and
the mitochondrial anti-oxidant enzyme superoxide dismutase (SOD2,
Stressgene). As we show in Fig. 3, the mRGCs were heavily stained
with antibodies against mitochondrial proteins, suggesting a high cel-
lular content of mitochondria, perhaps even higher than conventional
RGCs.
5. Conclusions and future directions
The photopigment melanopsin was our initial candidate for confer-
ring mRGC resistance to metabolic injury, associated with mitochon-
drial dysfunction in inherited optic neuropathies such as LHON and
DOA. According to the hypothesis put forward by Osborne and col-
leagues (Osborne et al., 2014), the melanopsin that allows for the in-
trinsic photosensitivity of mRGCs, may also protect the cells by quench-
ing against damaging effects of light. The conventional RGCs may be
more vulnerable in conditions characterized by mitochondrial dysfunc-
tion. However, there are accumulating evidences against a major role
of melanopsin in mRGC resistance to injury. In fact, the DOA mouse
model crossed with OPN4⁠−/− mouse, thus lacking melanopsin expres-
sion, still maintains intact the mRGC subpopulation, which survives mi
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Fig. 1. Effect of Rotenone and TBH on HEK cell survival during darkness. Panel A shows the effect of increasing concentrations (0.5 μM, 2.5 μM and 5 μM) of rotenone on cell survival.
White and blue bars are results of control cells and melanopsin expressing cells, respectively. Left and right half of the figure shows results obtained in the presence or absence of the
chromophore retinal, respectively. Panel B shows the effect of increasing concentrations (50 μM, 100 μM and 200 μM) of TBH on cell survival. White and blue bars are results of control
cells and melanopsin expressing cells, respectively. Left and right half of the figure shows results obtained in the presence or absence of the chromophore retinal, respectively. Each bar
shows the mean ± SEM (n = 3). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
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Fig. 2. Effect of Rotenone and TBH on HEK cell survival after light exposure. Panel A shows the effect on cell survival of increasing concentrations (0.5 μM, 2.5 μM and 5 μM) of
rotenone. White and blue bars are results of control cells and melanopsin expressing cells, respectively. Left and right half of the figure shows results obtained in the presence or absence
5
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of the chromophore retinal, respectively. Each bar shows the mean ± SEM (n = 3). Panel B shows the effect on cell survival of increasing concentrations (50 μM, 100 μM and 200 μM)
of TBH. White and blue bars are results of control cells and melanopsin expressing cells, respectively. Each bar shows the mean ± SEM (n = 6).To test whether melanopsin affected cell
survival during oxidative stress, we exposed cells to light for 24 h. Similarly to the previous experiment, cellular expression of melanopsin did not change cell viability during long light
exposures (data not shown). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
Fig. 3. Immunohistochemistry assessment of mitochondria in mRGCs. Serial retinal sections immunostained with antibodies against melanopsin (A), a mitochondrial extract (B), and the
mitochondrial respiratory chain subunit ND6 (C), counterstained by haematoxylin to highlight the nuclei. Asterisk and hash indicates respectively large and small conventional RGCs,
mRGCs are highlighted by arrow. Both large conventional RGCs and mRGCs stain heavily with mitochondrial antibodies (original magnification 40 ×).
tochondrial dysfunction without melanopsin (González-Menéndez et al.,
2015). Similarly, our in-vitro results using the HEK-hMel cell model
with inducible expression of melanopsin and under different paradigms
of light and stress exposure, clearly showed a lack of protective effects
of melanopsin on cell viability. Thus, the mechanisms providing mRGC
robustness to injury, in particular to mitochondrial dysfunction, must be
different. Furthermore, our data on human retinal specimens showing
that mRGCs are metabolically active with abundant mitochondrial mass
may have another interpretation. The abundant mitochondrial popula-
tion may reflect some compensatory and possibly even protective effect
in impaired mitochondria. This has been recently suggested by the com-
pensatory role exerted by mitochondrial biogenesis in regulating LHON
penetrance (Giordano et al., 2014). Alternatively, the high mitochondr-
ial activity in mRGCs may also indicate that they are deeply energy-de-
pendent and, thus, potentially vulnerable to mitochondrial dysfunction,
as suggested by the reported role of calcium management in mRGCs
(Peinado et al., 2015; Kumbalasiri et al., 2007; Hartwick et al., 2007).
A further point of discussion relates to the differential vulnerability of
mRGCs in view of the vulnerability of small axons in mitochondrial op-
tic neuropathies (Pan et al., 2012). Remarkably, the vast majority of
mRGCs are characterized by large cell bodies (Hannibal et al., 2004)
putting them in the category that is naturally preferentially spared in
LHON and DOA (Sadun et al., 2000). There is clearly a need for further
studies specifically addressing mitochondrial metabolism in mRGCs and
its relationship with calcium and photoreception.
Another natural candidate, besides melanopsin, for mRGC neuro-
protection, is the neuropeptide pituitary adenylate cyclase-activating
polypeptide (PACAP). This neuropeptide is selectively expressed by
mRGCs and not by conventional RGCs (Hannibal et al., 2002; Hannibal,
2006) and there is evidence for its possible role in mRGCs robustness.
Recently, one more hypothesis has been put forward to explain
mRGC robustness specific to injuries such as axonal transection. Such
survival seems to be limited to selective subtypes of mRGCs, in par-
ticular the M1 subpopulation, which has collateral projections into the
retina, iris and ciliary marginal zone (Joo et al., 2013; Schmidt et al.,
2013; Semo et al., 2014). These collateral axons may provide a reservoir
for trophic support of the mRGCs after transection of the main axon.
The corollary of this hypothesis would be that surviving mRGCs should
be mostly M1 also in mitochondrial optic neuropathies, thus we are cur-
rently investigating this issue in retinas from LHON and DOA patients.
The proven vulnerability of mRGCs in AD may turn out to be a more
general feature of neurodegeneration associated with accumulation of
misfolded proteins. In this regard, Parkinson's disease (PD) may provide
a further model of this pathogenic mechanism, as there is some evi-
dence of alpha-synuclein retinal deposition and circadian disturbances
amongst PD patients with non- motor symptoms.
In conclusion, the mRGC system is a fascinating model to further in-
vestigate for factors that may mitigate neuronal death in degenerative
neurological conditions. We should take advantage of the vagaries of
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human diseases to better understand the functions of mRGCs and espe-
cially to explore their robustness and vulnerability to injury and neu-
rodegeneration.
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